Contract research organization Genewiz has partnered with biotechnology company BeiGene to accelerate cancer biomarker discovery to support drug target identification Under the deal, BeiGene will leverage OncoGxOne discovery cancer panels ...
Tags: Genewiz, Beigene, Cancer Biomarker Discovery
Pharmaceutical research and development company Serina Therapeutics has partnered with the Scripps Research Institute to jointly develop polymer-antibody drug conjugates (Polymer-ADCs). Terms and financial details of the deal have not ...
Tags: Polymer-Antibody Drug, Medicine
Pharmaceutical firm Merck reported a net income of $906m, or $0.30 per share for the second quarter ended on 30 June 2013 compared to $1.8bn, or $0.58 per share in 2012. Total revenue for the second quarter ended on 30 June 2013 was ...
Tags: Merck, Pharmaceutical firm
Pfizer is planning for internal classification of its commercial operations into three business segments, which will include developed and emerging markets, in an effort to deliver value to consumers and patients. The three business ...
Tags: Pfizer, Commercial Businesses
Elekta, a Sweden-based medical technology company, has received CE Mark for its Clarity 4D Monitoring system. 4D monitoring offers continuous tracking of the prostate and imaging of the surrounding anatomy, including the bladder, rectum ...
Indian based pharmaceutical company Cipla has completed the acquisition of Cipla Medpro South Africa for a consideration of ZAR4.507bn ($456.43m). Commenting on the development Cipla managing director and global CEO Subhanu Saxena was ...
Tags: Cipla, Cipla Medpro
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
Oncology-focused drug development company Curis has obtained the conditional approval for Erivedge (vismodegib) to treat adult patients with symptomatic metastatic basal cell carcinoma (BCC) or locally advanced BCC inappropriate for surgery ...
Pfizer's rheumatoid arthritis treatment, tofacitinib, has obtained approval in several additional countries globally, including Switzerland, Argentina, Kuwait, UAE and Russia for patients with inadequate response to current therapies. The ...
The US Food and Drug Administration (FDA) has cleared Boehringer Ingelheim's tyrosine kinase inhibitor Gilotrif (afatinib) as a new medication for patients with late stage (metastatic) non-small cell lung cancer (NSCLC). The approval also ...
Tags: FDA, Lung Cancer Therapy, Medicine
The American Institute of Architects (AIA) Academy of Architecture for Health (AAH) has selected the recipients of the AIA National Healthcare Design Awards program. The AIA Healthcare Awards program showcases the best of healthcare ...
Tags: Lights, Lighting, Construction
Janssen Research & Development is seeking FDA approval for use of ibrutinib in the treatment of previously treated patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). The ...
Tags: FDA Approval, Janssen
US-based NanoString Technologies has announced that its Prosigna Breast Cancer Prognostic Gene Signature Assay offers better prognostic information in endocrine treated patients with HR+ node negative disease. NanoString Technologies said ...
Tags: Prognostic Information, Medicine
US-based NanoString Technologies has announced that its Prosigna Breast Cancer Prognostic Gene Signature Assay offers better prognostic information in endocrine treated patients with HR+ node negative disease. NanoString Technologies said ...
Tags: Prognostic Information, Medicine
Oncology-focused drug development company Curis has secured US patent protecting intellectual property rights of its phosphoinositide 3-kinase (PI3K) - histone deacetylase (HDAC) inhibitor, CUDC-907. The patent covers the method of ...
Tags: Health&Medicine, Curis, US